A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia April 2020 20(4):226-233 - Subject
- Language
- ISSN
- 2152-2650